CPBCampbell's Company (The)
- Next report
- Dec 8
- Tuesday, in 26 days · time not announced yet
- EPS expected
- $0.44
- quarter ending Oct 31, 2026
- Price
- $22.06
- −1.12% today · $6.83B cap
Past and upcoming reports
2
| Dec 8, 2026 | Oct 31, 2026 | Time not announced yet | $0.44 | not yet | |
| Jun 1, 2026 | Apr 30, 2026 | Time not given | $0.47 | not recorded | −0.57%2d |
Pre-earnings read
No pre-earnings read for this report
None for this company right now.
After the report
Jun 1, 2026 report
Campbell's Q3 estimates indicate ongoing sales and earnings pressure. shares declined post-report
Campbell's reported Q3 earnings with no EPS data available. shares fell 0.66% amid weak growth signals and cautious guidance. Valuation remains cheap but growth outlook is negative, with EPS expected to decline nearly 10% next year. The market reflects mixed sentiment with heavy short interest and a hold-tilted analyst consensus.
Reported against expected
Reported EPS not available. consensus estimate was $0.47 for Q3 ending April 30, 2026.
Guidance
Guidance tone suggests continued sales and earnings pressure. EPS next year expected to decline by 9.8%.
How the stock reacted
Shares declined 0.66% on the report day, reflecting investor caution amid weak growth signals.
What changed
Q3 earnings released with no EPS reported. shares declined 0.66% amid weak growth signals.
What the price now assumes
Market prices cautious outlook with share decline and heavy short interest at 22.6%.
What it means for the business
Maintain neutral stance. watch June 8 earnings for confirmation of sales and earnings trend.
The next one to three months, as we saw it then
Better case25%
Earnings on June 8 confirm stabilization or improvement in sales and earnings pressure, supporting valuation re-rating.
Base case50%
Earnings remain pressured with modest declines. valuation discount persists reflecting weak growth but stable cash flow.
Worse case25%
Earnings and sales deteriorate further, driving share price lower amid valuation multiple contraction and increased short interest.
If you hold it
Hold unless next-quarter revenue misses guidance materially or customer concentration risk worsens.
If you are watching
Consider entry only if June 8 earnings confirm EPS stabilization or growth. avoid if guidance worsens.
Scenario odds are a judgement, not measured.